Published in Oncol Lett on March 03, 2015
Potential role of microRNA-126 in the diagnosis of cancers: A systematic review and meta-analysis. Medicine (Baltimore) (2016) 0.76
Human mesenchymal stem cell homing induced by SKOV3 cells. Am J Transl Res (2017) 0.75
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta (2006) 4.27
p21-activated kinases in cancer. Nat Rev Cancer (2006) 4.24
PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J (1998) 2.62
miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett (2010) 2.17
p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients. Proc Natl Acad Sci U S A (2010) 1.50
miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun (2009) 1.38
Pak4, a novel Gab1 binding partner, modulates cell migration and invasion by the Met receptor. Mol Cell Biol (2009) 1.23
PAK4: a pluripotent kinase that regulates prostate cancer cell adhesion. J Cell Sci (2010) 1.17
Clinical significance of miR-126 in colorectal cancer. Genes Chromosomes Cancer (2014) 1.09
Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One (2011) 1.08
The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim Pol (2012) 1.07
Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways. Mol Cancer Res (2012) 1.06
P21 activated kinases: structure, regulation, and functions. Small GTPases (2014) 1.06
Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med (2012) 1.04
LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells. Cancer Lett (2011) 1.04
PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways. Biosci Rep (2014) 1.00
PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/Erk-dependent pathways. Biosci Rep (2014) 0.99
P21-activated kinase 4--not just one of the PAK. Eur J Cell Biol (2013) 0.99
Current status and implications of microRNAs in ovarian cancer diagnosis and therapy. J Ovarian Res (2012) 0.98
PAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasis. Oncogene (2013) 0.97
Epigenetic silencing of miR-126 contributes to tumor invasion and angiogenesis in colorectal cancer. Oncol Rep (2013) 0.96
P21-activated kinase 4 (PAK4) is required for metaphase spindle positioning and anchoring. Oncogene (2012) 0.93
Actin-associated protein palladin promotes tumor cell invasion by linking extracellular matrix degradation to cell cytoskeleton. Mol Biol Cell (2014) 0.91
Hypoxia-induced miR-210 in epithelial ovarian cancer enhances cancer cell viability via promoting proliferation and inhibiting apoptosis. Int J Oncol (2014) 0.91
The pak4 protein kinase in breast cancer. ISRN Oncol (2012) 0.88
p21-activated kinases regulate actin remodeling in glomerular podocytes. Am J Physiol Renal Physiol (2010) 0.88
Loss of miR-126 is crucial to pancreatic cancer progression. Expert Rev Anticancer Ther (2012) 0.87
Role of microRNA-133a in epithelial ovarian cancer pathogenesis and progression. Oncol Lett (2014) 0.86
Five-year relative survival rate of ovarian cancer in the USA, Europe and Japan. Jpn J Clin Oncol (2014) 0.84
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics. BMC Cancer (2013) 0.83